Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""ccl19"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 523
Tytuł:
Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.
Autorzy:
Ma R; Department of Epidemiology, Dalian Medical University, Dalian, China.
Guan X; Department of Epidemiology, Dalian Medical University, Dalian, China.
Teng N; Department of Epidemiology, Dalian Medical University, Dalian, China.
Du Y; Department of Epidemiology, Dalian Medical University, Dalian, China.
Ou S; Department of Epidemiology, Dalian Medical University, Dalian, China.
Li X; Department of Epidemiology, Dalian Medical University, Dalian, China. lxf_.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2023 Oct 21; Vol. 16 (1), pp. 254. Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/pathology
RNA, Long Noncoding*/genetics
MicroRNAs*/genetics
MicroRNAs*/metabolism
Humans ; Female ; Chemokine CCL19/genetics ; Chemokine CCL19/metabolism ; Prognosis ; Receptors, CCR7/genetics ; Receptors, CCR7/metabolism ; Biomarkers, Tumor/genetics ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anti-HER2 scFv-CCL19-IL7 recombinant protein inhibited gastric tumor growth in vivo.
Autorzy:
Zhang H; Department of Surgery, Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050017, Hebei, China.; Department of Oncology &Surgery, Hebei General Hospital, 348 West Heping Road, Shijiazhuang, 050051, Hebei, China.; Department of Surgery, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
Ye X; Department of Surgery, Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050017, Hebei, China.; Department of Oncology &Surgery, Hebei General Hospital, 348 West Heping Road, Shijiazhuang, 050051, Hebei, China.
Wen J; Department of Oncology &Surgery, Hebei General Hospital, 348 West Heping Road, Shijiazhuang, 050051, Hebei, China.
Cai Z; Hebei Cell Therapy Technology Innovation Center, HOFOY Medicine Hebei Co., LTD, 238 Yangzi River Avenue, Shijiazhuang, 050000, China.
Li Y; Department of Surgery, Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050017, Hebei, China.; Department of Oncology &Surgery, Hebei General Hospital, 348 West Heping Road, Shijiazhuang, 050051, Hebei, China.
Zhang M; Hebei Cell Therapy Technology Innovation Center, HOFOY Medicine Hebei Co., LTD, 238 Yangzi River Avenue, Shijiazhuang, 050000, China.
Shen L; Hebei Cell Therapy Technology Innovation Center, HOFOY Medicine Hebei Co., LTD, 238 Yangzi River Avenue, Shijiazhuang, 050000, China.
Cai J; Department of Surgery, Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang, 050017, Hebei, China. .; Department of Oncology &Surgery, Hebei General Hospital, 348 West Heping Road, Shijiazhuang, 050051, Hebei, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jun 21; Vol. 12 (1), pp. 10461. Date of Electronic Publication: 2022 Jun 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemokine CCL19*/genetics
Chemokine CCL19*/pharmacology
Interleukin-7*/genetics
Interleukin-7*/pharmacology
Receptors, Chimeric Antigen*
Recombinant Fusion Proteins*/genetics
Recombinant Fusion Proteins*/pharmacology
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/genetics
Antibodies, Monoclonal/genetics ; Antibodies, Monoclonal/pharmacology ; Cell Line, Tumor ; Humans ; Receptor, ErbB-2/immunology ; Receptor, ErbB-2/metabolism ; Single-Chain Antibodies/genetics ; Single-Chain Antibodies/pharmacology ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
Autorzy:
Brandum EP; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Jørgensen AS; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Calvo MB; Evaxion Biotech A/S, 2970 Horsholm, Denmark.
Spiess K; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Virus and Microbiological Special Diagnostics, Statens Serum Institut, 2300 Copenhagen, Denmark.
Peterson FC; Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Yang Z; Copenhagen Center for Glycomics, University of Copenhagen, Noerregade 10, 1165 Copenhagen, Denmark.
Volkman BF; Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Veldkamp CT; Department of Chemistry, University of Wisconsin-Whitewater, Whitewater, WI 53190, USA.
Rosenkilde MM; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Goth CK; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Hjortø GM; Department of Biomedical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jan 26; Vol. 23 (3). Date of Electronic Publication: 2022 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Chemokine CCL19*/metabolism
Chemokine CCL21*/metabolism
Peptides*/metabolism
Peptides*/pharmacology
Receptors, CCR7*/metabolism
Ligands ; Signal Transduction ; T-Lymphocytes/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Therapeutic effects of anti-GM2 CAR-T cells expressing IL-7 and CCL19 for GM2-positive solid cancer in xenograft model.
Autorzy:
Sasaki T; Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan.; Department of Endocrinology, Metabolism, Hematological Science and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Sakoda Y; Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Adachi K; Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Tokunaga Y; Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan.; Department of Endocrinology, Metabolism, Hematological Science and Therapeutics, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Tamada K; Department of Immunology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (11), pp. 12569-12580. Date of Electronic Publication: 2023 Apr 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Receptors, Chimeric Antigen*/genetics
Receptors, Chimeric Antigen*/metabolism
Neoplasms*/metabolism
Mice ; Animals ; Humans ; Interleukin-7/metabolism ; Heterografts ; T-Lymphocytes ; Chemokine CCL19/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Atlas of the anatomical localization of atypical chemokine receptors in healthy mice.
Autorzy:
Melgrati S; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Radice E; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Ameti R; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Hub E; Centre for Microvascular Research, The William Harvey Research Institute, Queen Mary University London, London, United Kingdom.
Thelen S; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Pelczar P; University of Basel, Center for Transgenic Models, Basel, Switzerland.
Jarrossay D; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Rot A; Centre for Microvascular Research, The William Harvey Research Institute, Queen Mary University London, London, United Kingdom.; Centre for Inflammation and Therapeutic Innovation, Queen Mary University London, London, United Kingdom.; Institute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich, Germany.
Thelen M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2023 May 09; Vol. 21 (5), pp. e3002111. Date of Electronic Publication: 2023 May 09 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Signal Transduction*
Animals ; Mice ; Chemokine CCL19/metabolism ; Cell Movement
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Important Role of the Chemokine Axis CCR7-CCL19 and CCR7-CCL21 in the Pathophysiology of the Immuno-inflammatory Response in Dry Eye Disease.
Autorzy:
Wang T; Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, P.R. China.
Li W; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, P.R. China.
Cheng H; Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, P.R. China.
Zhong L; Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, P.R. China.
Deng J; Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, P.R. China.
Ling S; Department of Ophthalmology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, P.R. China.
Pokaż więcej
Źródło:
Ocular immunology and inflammation [Ocul Immunol Inflamm] 2021 Feb 17; Vol. 29 (2), pp. 266-277. Date of Electronic Publication: 2019 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
Gene Expression Regulation*
Immunity, Cellular*
Chemokine CCL19/*genetics
Chemokine CCL21/*genetics
Dry Eye Syndromes/*genetics
Inflammation/*genetics
Receptors, CCR7/*genetics
Animals ; Cell Movement ; Chemokine CCL19/biosynthesis ; Chemokine CCL21/biosynthesis ; Disease Models, Animal ; Dry Eye Syndromes/immunology ; Dry Eye Syndromes/metabolism ; Female ; Flow Cytometry ; Inflammation/immunology ; Inflammation/metabolism ; Mice ; Mice, Inbred C57BL ; RNA/genetics ; Receptors, CCR7/biosynthesis ; Tears/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism.
Autorzy:
Vanalken N; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Boon K; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Doijen J; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Schols D; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Van Loy T; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Aug 10; Vol. 23 (16). Date of Electronic Publication: 2022 Aug 10.
Typ publikacji:
Journal Article
MeSH Terms:
Chemokine CCL21*/metabolism
Chemokines, C*/metabolism
Chemokine CCL19/metabolism ; Chemokines/metabolism ; Electric Impedance ; HEK293 Cells ; Humans ; Ligands ; Receptors, CCR7/metabolism ; beta-Arrestins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Does CCL19 act as a double-edged sword in cancer development?
Autorzy:
Gowhari Shabgah A; School of Medicine, Bam University of Medical Sciences, Bam, Iran.
Al-Obaidi ZMJ; Department of Pharmaceutical Chemistry, College of Pharmacy, University of Alkafeel, Najaf, Iraq.; Department of Chemistry and Biochemistry, College of Medicine, University of Kerbala, Karbala, Iraq.
Sulaiman Rahman H; Department of Physiology, College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq.; Department of Medical Laboratory Sciences, Komar University of Science and Technology, Sulaimaniyah, Iraq.
Kamal Abdelbasset W; Department of Health and Rehabilitation Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia.; Department of Physical Therapy, Kasr Al-Aini Hospital, Cairo University, Giza, Egypt.
Suksatan W; Faculty of Nursing, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand.
Bokov DO; Institute of Pharmacy, Sechenov First Moscow State Medical University, Moscow, Russian Federation.; Laboratory of Food Chemistry, Federal Research Center of Nutrition, Biotechnology and Food Safety, Moscow, Russian Federation.
Thangavelu L; Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha institute of medical and Technical Sciences, Saveetha University, Chennai, India.
Turki Jalil A; Faculty of Biology and Ecology, Yanka Kupala State University of Grodno, Grodno, Belarus.; College of Technical Engineering, The Islamic University, Najaf, Iraq.
Jadidi-Niaragh F; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammadi H; Department of Immunology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Mashayekhi K; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.; Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Gholizadeh Navashenaq J; Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
Pokaż więcej
Źródło:
Clinical and experimental immunology [Clin Exp Immunol] 2022 Apr 04; Vol. 207 (2), pp. 164-175.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lung Neoplasms*/metabolism
Lymph Nodes*
Chemokine CCL19/metabolism ; Chemokines/metabolism ; Humans ; Neovascularization, Pathologic ; Prognosis ; Receptors, CCR7/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Inhibition of CCL19 benefits non‑alcoholic fatty liver disease by inhibiting TLR4/NF‑κB‑p65 signaling.
Autorzy:
Zhao J; Department of Traditional Chinese Medicine, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China.
Wang Y; Department of Traditional Chinese Medicine, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China.
Wu X; Department of Endocrinology, Huashan Hospital, Fu Dan University, Shanghai 200040, P.R. China.
Tong P; Department of Endocrinology, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China.
Yue Y; Department of Traditional Chinese Medicine, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China.
Gao S; Department of Traditional Chinese Medicine, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China.
Huang D; Department of General Surgery, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China.
Huang J; Department of General Surgery, Putuo District People's Hospital of Shanghai City, Shanghai 200060, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2018 Nov; Vol. 18 (5), pp. 4635-4642. Date of Electronic Publication: 2018 Sep 14.
Typ publikacji:
Journal Article
MeSH Terms:
Chemokine CCL19/*genetics
Non-alcoholic Fatty Liver Disease/*drug therapy
Toll-Like Receptor 4/*genetics
Transcription Factor RelA/*genetics
AMP-Activated Protein Kinase Kinases ; Alanine Transaminase/blood ; Animals ; Aspartate Aminotransferases/blood ; Berberine/administration & dosage ; Chemokine CCL19/antagonists & inhibitors ; Diet, High-Fat/adverse effects ; Disease Models, Animal ; Dyslipidemias/blood ; Dyslipidemias/genetics ; Gene Expression Regulation ; Humans ; Interleukin-6/genetics ; Liver/drug effects ; Liver/pathology ; Metformin/administration & dosage ; Non-alcoholic Fatty Liver Disease/blood ; Non-alcoholic Fatty Liver Disease/genetics ; Non-alcoholic Fatty Liver Disease/pathology ; Protein Kinases ; Rats ; Signal Transduction ; Triglycerides/blood ; Tumor Necrosis Factor-alpha/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Shifting CCR7 towards Its Monomeric Form Augments CCL19 Binding and Uptake.
Autorzy:
Gerken OJ; Biotechnology Institute Thurgau (BITg), University of Konstanz, CH-8280 Kreuzlingen, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, CH-3012 Bern, Switzerland.
Artinger M; Biotechnology Institute Thurgau (BITg), University of Konstanz, CH-8280 Kreuzlingen, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, CH-3012 Bern, Switzerland.
Legler DF; Biotechnology Institute Thurgau (BITg), University of Konstanz, CH-8280 Kreuzlingen, Switzerland.; Theodor Kocher Institute, University of Bern, CH-3012 Bern, Switzerland.; Faculty of Biology, University of Konstanz, D-78464 Konstanz, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Apr 25; Vol. 11 (9). Date of Electronic Publication: 2022 Apr 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemokine CCL21*/metabolism
Chemokine CCL21*/pharmacology
Signal Transduction*
Chemokine CCL19/metabolism ; Humans ; Ligands ; Protein Binding ; Receptors, CCR7/genetics ; Receptors, CCR7/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low CCL19 expression is associated with adverse clinical outcomes for follicular lymphoma patients treated with chemoimmunotherapy.
Autorzy:
Zhou Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang S; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Tao Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Chen H; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Qin Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
He X; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Zhou S; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Liu P; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Yang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Yang S; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Gui L; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Lou N; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Zhang Z; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Yao J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Han X; Clinical Pharmacology Research Center, Peking Union Medical College Hospital, State Key Laboratory of Complex Severe and Rare Diseases, NMPA Key Laboratory for Clinical Research and Evaluation of Drug, Beijing Key Laboratory of Clinical PK & PD Investigation for Innovative Drugs, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 41 Damucang Hutong, Xicheng District, Beijing, 100032, China. .
Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2021 Sep 20; Vol. 19 (1), pp. 399. Date of Electronic Publication: 2021 Sep 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Follicular*/drug therapy
Lymphoma, Follicular*/genetics
Chemokine CCL19 ; Gene Ontology ; Humans ; Kaplan-Meier Estimate ; Prognosis ; Progression-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mast Cells and Basophils in the Defense against Ectoparasites: Efficient Degradation of Parasite Anticoagulants by the Connective Tissue Mast Cell Chymases.
Autorzy:
Fu Z; The Biomedical Center, Department of Cell and Molecular Biology, Uppsala University, SE-751 24 Uppsala, Sweden.
Akula S; The Biomedical Center, Department of Cell and Molecular Biology, Uppsala University, SE-751 24 Uppsala, Sweden.
Olsson AK; Department of Medical Biochemistry and Microbiology, BMC, SE-751 23 Uppsala, Sweden.
Kervinen J; Tosoh Bioscience LLC., 3604 Horizon Drive, King of Prussia, PA 19406, USA.
Hellman L; The Biomedical Center, Department of Cell and Molecular Biology, Uppsala University, SE-751 24 Uppsala, Sweden.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Nov 23; Vol. 22 (23). Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Antithrombin Proteins/*chemistry
Basophils/*enzymology
Chymases/*metabolism
Mast Cells/*enzymology
Parasites/*metabolism
Adaptive Immunity ; Animals ; Chemokine CCL19/chemistry ; Culicidae/metabolism ; Humans ; Immunoglobulin E/metabolism ; Leeches/metabolism ; Mice ; Proteolysis ; Proto-Oncogene Proteins c-sis/chemistry ; Ticks/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin.
Autorzy:
Pang N; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.; Department of Nutrition; Guangdong Provincial Key Laboratory of Food, School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Shi J; Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Center for Cell Regeneration and Biotherapy, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.; University of Chinese Academy of Science, Beijing, 100049, China.
Qin L; Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Center for Cell Regeneration and Biotherapy, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
Chen A; Department of Radiology, Qianjiang Central Hospital, Qianjiang, Hubei, China.
Tang Y; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Yang H; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Huang Y; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Wu Q; Department of Radiology, Shunde Chinese Medicine Hospital, The Affiliated Hospital of Traditional Chinese Medicine University of Guangzhou, Foshan, China.
Li X; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
He B; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Li T; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Liang B; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Zhang J; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Cao B; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Liu M; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Feng Y; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Ye X; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Chen X; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Wang L; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Tian Y; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Li H; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Li J; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Hu H; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
He J; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Hu Y; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Zhi C; Department of Pathology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Tang Z; Guangdong Zhaotai Cell Biology Technology Ltd., Guangzhou, China.; Guangdong Zhaotai InVivo Biomedicine Co. Ltd., Guangzhou, China.
Gong Y; The Second Xiangya Hospital, Central South University, Changsha, China.
Xu F; Xiangya Hospital, Central South University, Changsha, China.
Xu L; Department of Interventional Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Fan W; Minimally Invasive Interventional Division; Department of Medical Imaging and Interventional Radiology; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Zhao M; Minimally Invasive Interventional Division; Department of Medical Imaging and Interventional Radiology; State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Chen D; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Lian H; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. .
Yang L; Department of Nutrition; Guangdong Provincial Key Laboratory of Food, School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong, China. .
Li P; Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Center for Cell Regeneration and Biotherapy, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. li_.
Zhang Z; Department of Radiology; Translational Medicine Center and Guangdong Provincial Education Department Key Laboratory of Nano-Immunoregulation Tumor Microenvironment, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2021 Jul 29; Vol. 14 (1), pp. 118. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji:
Clinical Trial, Phase I; Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemokine CCL19/*immunology
GPI-Linked Proteins/*analysis
Glypicans/*analysis
Immunotherapy, Adoptive/*methods
Interleukin-7/*immunology
Neoplasms/*therapy
Animals ; Carcinoma, Hepatocellular/immunology ; Carcinoma, Hepatocellular/therapy ; Female ; GPI-Linked Proteins/immunology ; Glypicans/immunology ; Hep G2 Cells ; Humans ; Liver Neoplasms/immunology ; Liver Neoplasms/therapy ; Mesothelin ; Mice ; Neoplasms/immunology ; Neoplasms/pathology ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/therapy ; Pancreatic Neoplasms/immunology ; Pancreatic Neoplasms/therapy ; T-Lymphocytes/immunology ; Treatment Outcome
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Combination of AAV-CCL19 and GPC3 CAR-T Cells in the Treatment of Hepatocellular Carcinoma.
Autorzy:
Meng M; Department of Emergency, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, China.
Wu YC; Department of Emergency, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, Jiangsu, China.
Pokaż więcej
Źródło:
Journal of immunology research [J Immunol Res] 2021 Sep 03; Vol. 2021, pp. 1782728. Date of Electronic Publication: 2021 Sep 03 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy, Adoptive*/methods
Carcinoma, Hepatocellular/*therapy
Chemokine CCL19/*genetics
Glypicans/*genetics
Liver Neoplasms/*therapy
Receptors, Chimeric Antigen/*immunology
T-Lymphocytes/*metabolism
Animals ; Carcinoma, Hepatocellular/immunology ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Chemotaxis/immunology ; Dependovirus/genetics ; Disease Models, Animal ; Gene Expression ; Genetic Vectors/administration & dosage ; Genetic Vectors/genetics ; Humans ; Immunologic Memory ; Liver Neoplasms/immunology ; Liver Neoplasms/pathology ; Mice ; Receptors, Chimeric Antigen/genetics ; T-Lymphocytes/immunology ; Treatment Outcome ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A microfluidic device for measuring cell migration towards substrate-bound and soluble chemokine gradients.
Autorzy:
Schwarz J; Institute of Science and Technology Austria (IST Austria), 3400, Klosterneuburg, Austria.
Bierbaum V; Institute of Science and Technology Austria (IST Austria), 3400, Klosterneuburg, Austria.
Merrin J; Institute of Science and Technology Austria (IST Austria), 3400, Klosterneuburg, Austria.
Frank T; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.
Hauschild R; Institute of Science and Technology Austria (IST Austria), 3400, Klosterneuburg, Austria.
Bollenbach T; Institute of Science and Technology Austria (IST Austria), 3400, Klosterneuburg, Austria.
Tay S; Department of Biosystems Science and Engineering, ETH Zürich, 4058, Basel, Switzerland.; Institute for Molecular Engineering, The University of Chicago, Chicago, IL, 60637, USA.
Sixt M; Institute of Science and Technology Austria (IST Austria), 3400, Klosterneuburg, Austria.
Mehling M; Institute of Science and Technology Austria (IST Austria), 3400, Klosterneuburg, Austria.; Department of Biomedicine and Neurology Department, University Hospital Basel, 4031, Basel, Switzerland.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Nov 07; Vol. 6, pp. 36440. Date of Electronic Publication: 2016 Nov 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemokine CCL19/*pharmacology
Chemokine CCL21/*pharmacology
Chemotaxis/*drug effects
Dendritic Cells/*physiology
Microfluidics/*methods
Animals ; Bone Marrow Cells/cytology ; Cell Movement/drug effects ; Cells, Cultured ; Chemokine CCL19/chemistry ; Chemokine CCL19/metabolism ; Chemokine CCL21/chemistry ; Dendritic Cells/cytology ; Fluorescein-5-isothiocyanate/chemistry ; Immobilized Proteins/chemistry ; Immobilized Proteins/metabolism ; Immobilized Proteins/pharmacology ; Lab-On-A-Chip Devices ; Mice ; Mice, Inbred C57BL ; Microfluidics/instrumentation ; Microscopy, Fluorescence ; Photobleaching ; Substrate Specificity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Weaning differentially affects mitochondrial function, oxidative stress, inflammation and apoptosis in normal and low birth weight piglets.
Autorzy:
Novais AK; Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, Sherbrooke, Quebec, Canada.; Department of Animal Science, Universidade Estadual de Londrina, Londrina, Paraná, Brazil.
Deschêne K; Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, Sherbrooke, Quebec, Canada.
Martel-Kennes Y; Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, Sherbrooke, Quebec, Canada.; Département des Sciences Animales, Université Laval, Ville de Québec, Québec, Canada.
Roy C; Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, Sherbrooke, Quebec, Canada.
Laforest JP; Département des Sciences Animales, Université Laval, Ville de Québec, Québec, Canada.
Lessard M; Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, Sherbrooke, Quebec, Canada.
Matte JJ; Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, Sherbrooke, Quebec, Canada.
Lapointe J; Agriculture and Agri-Food Canada, Sherbrooke Research and Development Centre, Sherbrooke, Quebec, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Feb 19; Vol. 16 (2), pp. e0247188. Date of Electronic Publication: 2021 Feb 19 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Weaning*
Apoptosis/*genetics
Mitochondria/*metabolism
Oxidative Stress/*genetics
Animals ; Birth Weight ; Chemokine CCL19/genetics ; Chemokine CCL19/metabolism ; Chemokine CXCL10/genetics ; Chemokine CXCL10/metabolism ; Down-Regulation ; Energy Metabolism/genetics ; Heme Oxygenase-1/genetics ; Heme Oxygenase-1/metabolism ; Inflammation/genetics ; Inflammation/metabolism ; Interleukin-1beta/genetics ; Interleukin-1beta/metabolism ; Intestinal Mucosa/metabolism ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism ; Swine ; Up-Regulation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
Autorzy:
Wang Z; Department of Hepatobiliary and Pancreas, The First People's Hospital of Jingmen, Jingmen, China.
Pan L; Department of Hepatobiliary and Pancreas, The First People's Hospital of Jingmen, Jingmen, China.
Guo D; Department of Hepatobiliary and Pancreas, Zhongnan Hospital of Wuhan University, Wuhan, China.
Luo X; Department of Hepatobiliary and Pancreas, The First People's Hospital of Jingmen, Jingmen, China.
Tang J; Department of Hepatobiliary and Pancreas, The First People's Hospital of Jingmen, Jingmen, China.
Yang W; Department of Hepatobiliary and Pancreas, The First People's Hospital of Jingmen, Jingmen, China.
Zhang Y; Department of Hepatobiliary and Pancreas, The First People's Hospital of Jingmen, Jingmen, China.
Luo A; Department of Anesthesiology, The First People's Hospital of Jingmen, Jingmen, China.
Gu Y; Department of Hepatobiliary and Pancreas, The First People's Hospital of Jingmen, Jingmen, China.
Pan Y; Department of Blood Transfusion, The First People's Hospital of Jingmen, Jingmen, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Jun; Vol. 10 (11), pp. 3808-3821. Date of Electronic Publication: 2021 May 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Transcriptome*
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*genetics
Adaptor Proteins, Signal Transducing/genetics ; Aged ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Chemokine CCL19/genetics ; Databases, Genetic ; Decision Support Techniques ; Female ; Gene Expression Profiling ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Nomograms ; Osteopontin/genetics ; Prognosis ; RNA, Messenger/metabolism ; RNA-Binding Proteins/genetics ; ROC Curve ; Receptors, Cytoplasmic and Nuclear/genetics ; Regression Analysis ; SOXC Transcription Factors/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
Autorzy:
Luo L; Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Tianhe Road 600, Guangzhou, 510630, China. .
Zhou H; Department of Gynecology of Traditional Chinese Medicine, Shanxi Academy of Traditional Chinese Medicine, Taiyuan, 030000, China.
Su H; Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Tianhe Road 600, Guangzhou, 510630, China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 May 17; Vol. 21 (1), pp. 553. Date of Electronic Publication: 2021 May 17.
Typ publikacji:
Journal Article
MeSH Terms:
Nomograms*
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*mortality
Kidney Neoplasms/*mortality
Tumor Microenvironment/*genetics
Age Factors ; Aged ; CD79 Antigens/genetics ; Carcinoma, Renal Cell/diagnosis ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/immunology ; Chemokine CCL19/genetics ; Chemokine CXCL13/genetics ; Datasets as Topic ; Feasibility Studies ; Female ; Gene Expression Regulation, Neoplastic/immunology ; Humans ; Interleukin-6/genetics ; Kaplan-Meier Estimate ; Kidney/immunology ; Kidney/pathology ; Kidney Neoplasms/diagnosis ; Kidney Neoplasms/genetics ; Kidney Neoplasms/immunology ; Male ; Middle Aged ; Models, Genetic ; Neoplasm Grading ; Protein Interaction Maps/genetics ; Protein Interaction Maps/immunology ; ROC Curve ; Risk Assessment/methods ; Risk Assessment/statistics & numerical data ; Sex Factors ; Tumor Microenvironment/immunology ; Up-Regulation/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 523

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies